Synthesis and structure-activity relationships of novel IKK-β inhibitors.: Part 3:: Orally active anti-inflammatory agents

被引:116
|
作者
Murata, T [1 ]
Shimada, M
Sakakibara, S
Yoshino, T
Masuda, T
Shintani, T
Sato, H
Koriyama, Y
Fukushima, K
Nunami, N
Yamauchi, M
Fuchikami, K
Komura, H
Watanabe, A
Ziegelbauer, KB
Bacon, KB
Lowinger, TB
机构
[1] Bayer Yakuhin Ltd, Res Ctr Kyoto, Dept Chem, Sora Ku, Kyoto 6190216, Japan
[2] Bayer Yakuhin Ltd, Res Ctr Kyoto, Dept Biol, Sora Ku, Kyoto 6190216, Japan
关键词
IKK-beta; NF-kappa B; kinase inhibitor;
D O I
10.1016/j.bmcl.2004.05.041
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2-amino-3-cyano-4-alkyl-6-(2-hydroxyphenyl)pyridine derivatives was synthesized and evaluated as IkappaB kinase beta (IKK-beta) inhibitors. Modification of a novel IKK-beta inhibitor 1 (IKK-beta IC50 = 1500 nM, Cell IC50 = 8000 nM) at the 4-phenyl ring and 6-phenol group on the pyridine core ring resulted in a marked increased in biological activities. An optimized compound, 2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-piperidin-4-yl nicotinonitrile, exhibited excellent in vitro profiles (IKK-beta IC50 = 8.5 nM, Cell IC50 = 60 nM) and a strong oral efficacy in in vivo anti-inflammatory assays (significant effects at 1 mg/kg, po in arachidonic acid-induced ear edema model in mice). (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4019 / 4022
页数:4
相关论文
共 50 条
  • [21] Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives
    Hisamichi, H
    Naito, R
    Toyoshima, A
    Kawano, N
    Ichikawa, A
    Orita, A
    Orita, M
    Hamada, N
    Takeuchi, M
    Ohta, M
    Tsukamoto, SI
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (16) : 4936 - 4951
  • [22] Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors
    Belema, Makonen
    Bunker, Amy
    Nguyen, Van N.
    Beaulieu, Francis
    Ouellet, Carl
    Qu, Yuping
    Zhang, Yunhui
    Martel, Alain
    Burke, James R.
    Mclntyre, Kim W.
    Pattoli, Mark A.
    Daloisio, Connie
    Gillooly, Kathleen M.
    Clarke, Wendy J.
    Brassil, Patrick J.
    Zusi, F. Chris
    Vyasa, Dolatrai M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (15) : 4284 - 4289
  • [23] Design, synthesis, and structure-activity relationships of a series of urea based MMP inhibitors.
    Chen, JJ
    Lin, XH
    Browner, MF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1214 - U1214
  • [24] Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads
    Ullman, BR
    Aja, T
    Chen, N
    Diaz, JL
    Gu, X
    Herrmann, J
    Kalish, VJ
    Karanewsky, DS
    Kodandapani, L
    Krebs, JJ
    Linton, SD
    Meduna, SP
    Nalley, K
    Robinson, ED
    Roggo, SP
    Sayers, RO
    Schmitz, A
    Ternansky, RJ
    Tomaselli, KJ
    Wu, JC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (15) : 3632 - 3636
  • [25] Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents
    Yarovaya, Olga, I
    Sokolova, Anastasiya S.
    Mainagashev, Iliya Ya
    Volobueva, Alexandrina S.
    Lantseva, Khristina
    Borisevich, Sophia S.
    Shtro, Anna A.
    Zarubaev, Vladimir V.
    Salakhutdinov, Nariman F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (23)
  • [26] Design, synthesis and structure-activity relationships of diaryl ethers as factor Xa inhibitors.
    Zhang, PL
    Zuckett, JMF
    Woolfrey, J
    Tran, K
    Huang, B
    Wong, P
    Sinha, U
    Park, G
    Reed, A
    Malinowski, J
    Hollenbach, S
    Scarborough, RM
    Zhu, BY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A92 - A93
  • [27] Synthesis and structure-activity relationships of N-[(7-amidino-2-naphthyl)-methyl]amide derivatives: Potent and orally active FXa inhibitors.
    Hirayama, F
    Koshio, H
    Taniuchi, Y
    Sato, K
    Hisamichi, N
    Sakai, Y
    Katayama, N
    Kurihara, H
    Kawasaki, T
    Matsumoto, Y
    Yanagisawa, I
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 49 - MEDI
  • [28] An Investigation on the Quantitative Structure-Activity Relationships of the Anti-Inflammatory Activity of Diterpenoid Alkaloids
    Li, Xiao
    Li, Ning
    Sui, Zhenyu
    Bi, Kaishun
    Li, Zuojing
    MOLECULES, 2017, 22 (03):
  • [29] Structure-activity relationships of orally active antimalarial acridones: Synthesis, optimization, and biological activity
    Kelly, Jane X.
    Smilkstein, Martin
    Winter, Rolf
    Dodean, Rosie
    Riscoe, Mike
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 251 - 251
  • [30] Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases
    McIver, Edward G.
    Bryans, Justin
    Birchall, Kristian
    Chugh, Jasveen
    Drake, Thomas
    Lewis, Stephen J.
    Osborne, Joanne
    Smiljanic-Hurley, Ela
    Tsang, William
    Kamal, Ahmad
    Levy, Alison
    Newman, Michelle
    Taylor, Debra
    Arthur, J. Simon C.
    Clark, Kristopher
    Cohen, Philip
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (23) : 7169 - 7173